**** SECTION 2 - COMPOSITION, INFORMATION ON INGREDIENTS ****
+----------------+--------------------------------------+----------+-----------+
| CAS# | Chemical Name | % | EINECS# |
|----------------|--------------------------------------|----------|-----------|
|----------------|--------------------------------------|----------|-----------|
| 71-23-8 |n-Propyl alcohol | 33 | 200-746-9 |
|----------------|--------------------------------------|----------|-----------|
| 104-76-7 |2-Ethylhexanol | 11 | 203-234-3 |
|----------------|--------------------------------------|----------|-----------|
| 111-27-3 |n-Hexanol | 33 | 203-852-3 |
|----------------|--------------------------------------|----------|-----------|
| 111-70-6 |n-Heptyl alcohol | 23 | 203-897-9 |
+----------------+--------------------------------------+----------+-----------+
Text for R-phrases: see Section 16
Hazard Symbols: XN
Risk Phrases: 10 21/22 36/37/38
**** SECTION 3 - HAZARDS IDENTIFICATION ****
EMERGENCY OVERVIEW
Flammable. Harmful in contact with skin and if swallowed. Irritating
to eyes, respiratory system and skin.
Potential Health Effects
Eye:
Causes eye irritation.
Skin:
Causes symptoms similar to those of inhalation. May be harmful if
absorbed through the skin. Excessive drying of the skin may result
from repeated or prolonged contact.
Ingestion:
Harmful if swallowed. May cause irritation of the digestive tract.
May cause liver and kidney damage. May cause central nervous system
depression, characterized by excitement, followed by headache,
dizziness, drowsiness, and nausea. Advanced stages may cause
collapse, unconsciousness, coma and possible death due to
respiratory failure. May cause effects similar to those for
inhalation exposure.
Inhalation:
Inhalation of high concentrations may cause central nervous system
effects characterized by nausea, headache, dizziness, unconsciousness
and coma. May cause respiratory tract irritation. Irritation may lead
to chemical pneumonitis and pulmonary edema. Aspiration may cause
respiratory swelling and pneumonitis. May cause kidney damage. May
cause drowsiness, unconsciousness, and central nervous system
depression.
Chronic:
Chronic inhalation and ingestion may cause effects similar to those
of acute inhalation and ingestion. Prolonged or repeated skin
contact may cause defatting and dermatitis.
**** SECTION 4 - FIRST AID MEASURES ****
Eyes:
Flush eyes with plenty of water for at least 15 minutes,
occasionally lifting the upper and lower eyelids. Get medical aid
immediately.
Skin:
Get medical aid. Flush skin with plenty of water for at least 15
minutes while removing contaminated clothing and shoes. Wash clothing
before reuse.
Ingestion:
Do not induce vomiting. If victim is conscious and alert, give 2-4
cupfuls of milk or water. Never give anything by mouth to an
unconscious person. Possible aspiration hazard. Get medical aid
immediately.
Inhalation:
Remove from exposure and move to fresh air immediately. If not
breathing, give artificial respiration. If breathing is difficult,
give oxygen. Get medical aid. Do NOT use mouth-to-mouth
resuscitation. If breathing has ceased apply artificial respiration
using oxygen and a suitable mechanical device such as a bag and a
mask.
Notes to Physician:
Urine acetone test may be helpful in diagnosis. Treat
symptomatically and supportively.
**** SECTION 5 - FIRE FIGHTING MEASURES ****
General Information:
Containers can build up pressure if exposed to heat and/or fire. As
in any fire, wear a self-contained breathing apparatus in
pressure-demand, MSHA/NIOSH (approved or equivalent), and full
protective gear. Vapors may form an explosive mixture with air.
During a fire, irritating and highly toxic gases may be generated by
thermal decomposition or combustion. Use water spray to keep
fire-exposed containers cool. Flammable liquid and vapor. May form
explosive peroxides. Vapors may be heavier than air. They can
spread along the ground and collect in low or confined areas.
Extinguishing Media:
Do NOT use straight streams of water. For small fires, use dry
chemical, carbon dioxide, water spray or regular foam. For large
fires, use water spray, fog or regular foam.
**** SECTION 6 - ACCIDENTAL RELEASE MEASURES ****
General Information: Use proper personal protective equipment as indicated
in Section 8.
Spills/Leaks:
Avoid runoff into storm sewers and ditches which lead to waterways.
Clean up spills immediately, observing precautions in the Protective
Equipment section. Remove all sources of ignition. Absorb spill using
an absorbent, non-combustible material such as earth, sand, or
vermiculite. Do not use combustible materials such as sawdust. Use a
spark-proof tool. Provide ventilation. A vapor suppressing foam may
be used to reduce vapors. Water spray may reduce vapor but may not
prevent ignition in closed spaces.
**** SECTION 7 - HANDLING and STORAGE ****
Handling:
Wash thoroughly after handling. Remove contaminated clothing and
wash before reuse. Use with adequate ventilation. Ground and bond
containers when transferring material. Use spark-proof tools and
explosion proof equipment. Avoid contact with eyes, skin, and
clothing. Empty containers retain product residue, (liquid and/or
vapor), and can be dangerous. Keep container tightly closed. Keep
away from heat, sparks and flame. Avoid ingestion and inhalation. Do
not pressurize, cut, weld, braze, solder, drill, grind, or expose
empty containers to heat, sparks or open flames.
Storage:
Keep away from heat, sparks, and flame. Keep away from sources of
ignition. Keep container closed when not in use. Store in a tightly
closed container. Store in a cool, dry, well-ventilated area away
from incompatible substances.
**** SECTION 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION ****
Engineering Controls:
Facilities storing or utilizing this material should be equipped
with an eyewash facility and a safety shower. Use adequate general or
local explosion-proof ventilation to keep airborne levels to
acceptable levels.
Personal Protective Equipment
Eyes:
Wear chemical goggles.
Skin:
Wear appropriate protective gloves to prevent skin
exposure.
Clothing:
Wear appropriate protective clothing to prevent skin
exposure.
Respirators:
Follow the OSHA respirator regulations found in 29
CFR 1910.134 or European Standard EN 149. Always use
a NIOSH or European Standard EN 149 approved
respirator when necessary.
**** SECTION 9 - PHYSICAL AND CHEMICAL PROPERTIES ****
Physical State: Liquid
Color: colorless
Odor: alcohol-like
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: Not available.
Autoignition Temperature: Not available.
Flash Point: 84 deg F ( 28.89 deg C)
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water:
Specific Gravity/Density:
Molecular Formula:
Molecular Weight:
**** SECTION 10 - STABILITY AND REACTIVITY ****
Chemical Stability:
Stable under normal temperatures and pressures. This material may be
sensitive to peroxide formation.
Conditions to Avoid:
High temperatures, ignition sources, excess heat.
Incompatibilities with Other Materials:
Strong oxidizing agents.
Hazardous Decomposition Products:
Carbon monoxide, irritating and toxic fumes and gases, carbon
dioxide.
Hazardous Polymerization: Will not occur.
**** SECTION 11 - TOXICOLOGICAL INFORMATION ****
RTECS#:
CAS# 71-23-8: UH8225000
CAS# 104-76-7: MP0350000
CAS# 111-27-3: MQ4025000
CAS# 111-70-6: MK0350000
LD50/LC50:
CAS# 71-23-8: Draize test, rabbit, eye: 20 mg/24H Moderate;
Inhalation, mouse: LC50 = 48 gm/m3; Inhalation, mouse: LC50 = 48000
mg/m3; Oral, mouse: LD50 = 6800 mg/kg; Oral, rabbit: LD50 = 2825
mg/kg; Oral, rat: LD50 = 1870 mg/kg; Oral, rat: LD50 = 2200 mg/kg;
Skin, rabbit: LD50 = 5040 mg/kg.
CAS# 104-76-7: Draize test, rabbit, eye: 20 mg Severe; Draize test,
rabbit, eye: 20 mg/24H Moderate; Draize test, rabbit, skin: 500
mg/24H Moderate; Oral, mouse: LD50 = 2500 mg/kg; Oral, rabbit: LD50
= 1180 mg/kg; Oral, rat: LD50 = 3730 mg/kg; Skin, rabbit: LD50 =
1970 mg/kg; Skin, rat: LD50 = >3 gm/kg.
CAS# 111-27-3: Oral, mouse: LD50 = 1950 mg/kg; Oral, mouse: LD50 =
1950 mg/kg; Oral, rat: LD50 = 720 mg/kg; Oral, rat: LD50 = 710 mg/kg;
Skin, rabbit: LD50 = 3100 uL/kg.
CAS# 111-70-6: Inhalation, mouse: LC50 = 6600 mg/m3/2H; Inhalation,
mouse: LC50 = 6000 mg/kg/2H; Oral, mouse: LD50 = 1500 mg/kg; Oral,
mouse: LD50 = 6000 mg/kg; Oral, rabbit: LD50 = 750 mg/kg; Oral, rat:
LD50 = 500 mg/kg; Oral, rat: LD50 = 3800 mg/kg; Skin, rabbit: LD50 =
2 gm/kg.
Carcinogenicity:
n-Propyl alcohol -
ACGIH: A3 - Confirmed animal carcinogen with unknown relevance to
2-Ethylhexanol -
Not listed by ACGIH, IARC, or NTP.
n-Hexanol -
Not listed by ACGIH, IARC, or NTP.
n-Heptyl alcohol -
Not listed by ACGIH, IARC, or NTP.
See actual entry in RTECS for complete information.
**** SECTION 12 - ECOLOGICAL INFORMATION ****
Other
No information available.
**** SECTION 13 - DISPOSAL CONSIDERATIONS ****
Dispose of in a manner consistent with federal, state, and local regulations.
**** SECTION 14 - TRANSPORT INFORMATION ****
IATA
No information available.
IMO
No information available.
RID/ADR
No information available.
**** SECTION 15 - REGULATORY INFORMATION ****
European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: XN
Risk Phrases:
R 10 Flammable.
R 21/22 Harmful in contact with skin and if
swallowed.
R 36/37/38 Irritating to eyes, respiratory system
and skin.
Safety Phrases:
S 16 Keep away from sources of ignition - No
smoking.
S 24/25 Avoid contact with skin and eyes.
S 26 In case of contact with eyes, rinse immediately
with plenty of water and seek medical advice.
S 36/37/39 Wear suitable protective clothing, gloves
and eye/face protection.
WGK (Water Danger/Protection)
CAS# 71-23-8: 1
CAS# 104-76-7: 2
CAS# 111-27-3: 1
CAS# 111-70-6: 1
United Kingdom Occupational Exposure Limits
CAS# 71-23-8: OES-United Kingdom, TWA 200 ppm TWA; 500 mg/m3 TWA
CAS# 71-23-8: OES-United Kingdom, STEL 250 ppm STEL; 625 mg/m3 STEL
CAS# 71-23-8: OES-United Kingdom, STEL 250 ppm STEL; 625 mg/m3 STEL
United Kingdom Maximum Exposure Limits
Canada
CAS# 71-23-8 is listed on Canada's DSL List.
CAS# 104-76-7 is listed on Canada's DSL List.
CAS# 111-27-3 is listed on Canada's DSL List.
CAS# 111-70-6 is listed on Canada's DSL List.
CAS# 71-23-8 is listed on Canada's Ingredient Disclosure List.
CAS# 104-76-7 is listed on Canada's Ingredient Disclosure List.
CAS# 111-27-3 is listed on Canada's Ingredient Disclosure List.
CAS# 111-70-6 is not listed on Canada's Ingredient Disclosure List.
Exposure Limits
CAS# 71-23-8: OEL-AUSTRALIA:TWA 200 ppm (500 mg/m3);STEL 250 ppm;Skin
CAS# 111-70-6: OEL-RUSSIA:STEL 10 mg/m3;Skin
US FEDERAL
TSCA
CAS# 71-23-8 is listed on the TSCA inventory.
CAS# 104-76-7 is listed on the TSCA inventory.
CAS# 111-27-3 is listed on the TSCA inventory.
CAS# 111-70-6 is listed on the TSCA inventory.
**** SECTION 16 - ADDITIONAL INFORMATION ****
MSDS Creation Date: 11/04/1999 Revision #6 Date: 9/13/2004
The information above is believed to be accurate and represents the best
information currently available to us. However, we make no warranty of
merchantability or any other warranty, express or implied, with respect to
such information, and we assume no liability resulting from its use. Users
should make their own investigations to determine the suitability of the
information for their particular purposes. In no way shall the company be
liable for any claims, losses, or damages of any third party or for lost
profits or any special, indirect, incidental, consequential or exemplary
damages, howsoever arising, even if the company has been advised of
the possibility of such damages.
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
|
|
|